164 related articles for article (PubMed ID: 20823886)
1. Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.
Campbell HE; Gray AM; Harris AL; Briggs AH; Taylor MA
Br J Cancer; 2010 Sep; 103(6):776-86. PubMed ID: 20823886
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
4. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
[TBL] [Abstract][Full Text] [Related]
6. An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
Campbell HE; Taylor MA; Harris AL; Gray AM
Br J Cancer; 2009 Oct; 101(7):1074-84. PubMed ID: 19724274
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial.
Smith I; Robertson J; Kilburn L; Wilcox M; Evans A; Holcombe C; Horgan K; Kirwan C; Mallon E; Sibbering M; Skene A; Vidya R; Cheang M; Banerji J; Morden J; Sidhu K; Dodson A; Bliss JM; Dowsett M
Lancet Oncol; 2020 Nov; 21(11):1443-1454. PubMed ID: 33152284
[TBL] [Abstract][Full Text] [Related]
8. Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index.
Liu MT; Huang WT; Wang AY; Huang CC; Huang CY; Chang TH; Pi CP; Yang HH
Support Care Cancer; 2010 Dec; 18(12):1553-64. PubMed ID: 19904562
[TBL] [Abstract][Full Text] [Related]
9. Prognostic models for breast cancer: a systematic review.
Phung MT; Tin Tin S; Elwood JM
BMC Cancer; 2019 Mar; 19(1):230. PubMed ID: 30871490
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Oncotype DX, PREDICT and the Nottingham Prognostic Index: Implications for the Management of Early Breast Cancer.
Hillyar C; Rizki H; Abbassi O; Miles-Dua S; Clayton G; Gandamihardja T; Smith S
Cureus; 2020 Apr; 12(4):e7552. PubMed ID: 32382456
[TBL] [Abstract][Full Text] [Related]
11. BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients.
Wischnewsky M; Schwentner L; Diessner JD; De Gregorio A; Joukhadar R; Davut D; Salmen J; Bekes I; Kiesel M; Müller-Reiter M; Blettner M; Wolters R; Janni W; Kreienberg R; Wöckel A; Ebner F
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206581
[TBL] [Abstract][Full Text] [Related]
12. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
13. A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy.
Kattan MW; Giri D; Panageas KS; Hummer A; Cranor M; Van Zee KJ; Hudis CA; Norton L; Borgen PI; Tan LK
Cancer; 2004 Dec; 101(11):2509-15. PubMed ID: 15495180
[TBL] [Abstract][Full Text] [Related]
14. Relationship of Oncotype Dx score with tumor grade, size, nodal status, proliferative marker Ki67 and Nottingham Prognostic Index in early breast cancer tumors in Saudi Population.
Durrani S; Al-Mushawa F; Heena H; Wani T; Al-Qahtani A
Ann Diagn Pathol; 2021 Apr; 51():151674. PubMed ID: 33360027
[TBL] [Abstract][Full Text] [Related]
15. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J
Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581
[TBL] [Abstract][Full Text] [Related]
16. Development of a Prognostic App (iCanPredict) to Predict Survival for Chinese Women With Breast Cancer: Retrospective Study.
Ma Z; Huang S; Wu X; Huang Y; Chan SW; Lin Y; Zheng X; Zhu J
J Med Internet Res; 2022 Mar; 24(3):e35768. PubMed ID: 35262503
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of nodal ratio on breast cancer recurrence and its potential for incorporation in a new prognostic index.
Martin FT; O'Fearraigh C; Hanley C; Curran C; Sweeney KJ; Kerin MJ
Breast J; 2013; 19(4):388-93. PubMed ID: 23721403
[TBL] [Abstract][Full Text] [Related]
18. [A new perspective on axillary dissection in situations of metastatic sentinel node].
Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
[TBL] [Abstract][Full Text] [Related]
19. Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?
Bundred NJ; Prasad R; Morris J; Knox WF; Byrne G; Cheung S; Wilson M; Lawrence G
Breast Cancer Res Treat; 2013 Apr; 138(2):359-68. PubMed ID: 21744241
[TBL] [Abstract][Full Text] [Related]
20. Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.
Jankowitz RC; Cooper K; Erlander MG; Ma XJ; Kesty NC; Li H; Chivukula M; Brufsky A
Breast Cancer Res; 2011 Oct; 13(5):R98. PubMed ID: 21999244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
